Senior Pediatric Endocrinologist, Director of the Scientific and Technology Diabetes Service, Institute for Endocrinology and Diabetes National Center for Childhood Diabetes Schneider Children's Medical Center of Israel, ISRAEL
Revital Nimri (MD) graduated from Technion, Haifa, Israel in 1991 and specialized in pediatrics and then in pediatric endocrinology in 2001-2006 at the Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel.
She is a pediatrician and senior endocrinologist taking care of patients with various endocrine disorders including patients with type 1 diabetes, monogenic diabetes and neonatal diabetes. Her research interests include basic and clinical research in pediatric diabetology with special emphasis on new insulins, insulin pumps, glucose sensors and the artificial pancreas. She is currently the Director of the scientific and Technology Diabetes Service and Diabetes Technology Center at Schneider. She has a 20-years track record of expertise in clinical diabetes and in the last decade she focuses solely on new and innovative technologies for the treatment of type 1 diabetes. Dr. Nimri is active in both development and clinical testing of automated insulin delivery systems and decision support systems. She had a key role in the initiation, the development process and design of the MD-Logic artificial pancreas, a unique clinical driven technology based on a fuzzy logic control algorithm. The MD-Logic was the first closed-loop system to be tested at home. She received academic and professional awards for clinical research in pediatric endocrinology and a special award for contribution to the research in diabetes mellitus from the Israel Diabetic Association. Currently, she is principal investigator of several large projects dedicated to the development and clinical testing in multi-center, multinational studies of closed-loop system and different advisory software for the treatment and management of type 1 diabetes. Dr. Nimri’s research is funded by the National Institute of Health, the Juvenile Diabetes Research Foundation, Helmsley charitable trust and Industrial partners.